US$ 22.05
do glp 1 drugs cause diarrhea on GLP-1: Causes, Relief, and Warning Signs Ozempic: Semaglutide is a GLP-1
Description
population and is currently the seventh leading cause of death
The India Anti-Obesity Drug Market is estimated to be valued at USD 1.24 Bn in 2026 and is expected to reach USD 4.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 19.7% from 2026 to 2032
Coverage varies significantly by plan and region
Research Areas (20242026) Direct Clinical Connections (2026 Context) Active research in 2026 is focusing on the neuroprotective potential of sitagliptin

Patients choosing compounded GLP-1 therapy don't sacrifice safety or effectiveness

November 2016.
